Jia-Bei Wang (Jiabei Wang)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Venues

Cell death & disease

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Nature communications

Oncogene

This page only lists publications with an associated author ORCID identifier.

Publications

Linmao Sun, Yufeng Liu, Xinyu Guo, Tianming Cui, Chenghui Wu, Jie Tao, Cheng Cheng, Qi Chu, Changyong Ji, Xianying Li, Hongrui Guo, Shuhang Liang, Huanran Zhou, Shuo Zhou, Kun Ma, Ning Zhang, Jia-Bei Wang, Yao Liu, Lian-Xin Liu
Acetylation-dependent regulation of core spliceosome modulates hepatocellular carcinoma cassette exons and sensitivity to PARP inhibitors. Nature communications 15 (1) (2024)
Kun Ma, Junhui Chu, Yufeng Liu, Linmao Sun, Shuo Zhou, Xianying Li, Changyong Ji, Ning Zhang, Xinyu Guo, Shuhang Liang, Tianming Cui, Qingsong Hu, Jia-Bei Wang, Yao Liu, Lian-Xin Liu
Hepatocellular Carcinoma LINC01116 Outcompetes T Cells for Linoleic Acid and Accelerates Tumor Progression. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (21) (2024)
Kun Ma, Junhui Chu, Yufeng Liu, Linmao Sun, Shuo Zhou, Xianying Li, Changyong Ji, Ning Zhang, Xinyu Guo, Shuhang Liang, Tianming Cui, Qingsong Hu, Jia-Bei Wang, Yao Liu, Lian-Xin Liu
Hepatocellular Carcinoma LINC01116 Outcompetes T Cells for Linoleic Acid and Accelerates Tumor Progression. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (21) (2024)
Linmao Sun, Yufeng Liu, Xinyu Guo, Tianming Cui, Chenghui Wu, Jie Tao, Cheng Cheng, Qi Chu, Changyong Ji, Xianying Li, Hongrui Guo, Shuhang Liang, Huanran Zhou, Shuo Zhou, Kun Ma, Ning Zhang, Jia-Bei Wang, Yao Liu, Lian-Xin Liu
Acetylation-dependent regulation of core spliceosome modulates hepatocellular carcinoma cassette exons and sensitivity to PARP inhibitors. Nature communications 15 (1) (2024)
Kun Ma, Junhui Chu, Yufeng Liu, Linmao Sun, Shuo Zhou, Xianying Li, Changyong Ji, Ning Zhang, Xinyu Guo, Shuhang Liang, Tianming Cui, Qingsong Hu, Jia-Bei Wang, Yao Liu, Lian-Xin Liu
Hepatocellular Carcinoma LINC01116 Outcompetes T Cells for Linoleic Acid and Accelerates Tumor Progression. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (21) (2024)
Kun Ma, Junhui Chu, Yufeng Liu, Linmao Sun, Shuo Zhou, Xianying Li, Changyong Ji, Ning Zhang, Xinyu Guo, Shuhang Liang, Tianming Cui, Qingsong Hu, Jia-Bei Wang, Yao Liu, Lian-Xin Liu
Hepatocellular Carcinoma LINC01116 Outcompetes T Cells for Linoleic Acid and Accelerates Tumor Progression. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Kun Ma, Junhui Chu, Yufeng Liu, Linmao Sun, Shuo Zhou, Xianying Li, Changyong Ji, Ning Zhang, Xinyu Guo, Shuhang Liang, Tianming Cui, Qingsong Hu, Jia-Bei Wang, Yao Liu, Lian-Xin Liu
Hepatocellular Carcinoma LINC01116 Outcompetes T Cells for Linoleic Acid and Accelerates Tumor Progression. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (21) (2024)
Linmao Sun, Yufeng Liu, Xinyu Guo, Tianming Cui, Chenghui Wu, Jie Tao, Cheng Cheng, Qi Chu, Changyong Ji, Xianying Li, Hongrui Guo, Shuhang Liang, Huanran Zhou, Shuo Zhou, Kun Ma, Ning Zhang, Jia-Bei Wang, Yao Liu, Lian-Xin Liu
Acetylation-dependent regulation of core spliceosome modulates hepatocellular carcinoma cassette exons and sensitivity to PARP inhibitors. Nature communications 15 (1) (2024)
Heng Li, Yao Liu, Can Cheng, Yang Wu, Shu-Hang Liang, Liang Wu, Hong Wang, Cong-Yin Tu, Han-Hui Yao, Fan-Zheng Meng, Bo Zhang, Wei Wang, Jia-Bei Wang, Lian-Xin Liu
UBE2O reduces the effectiveness of interferon-α via degradation of IFIT3 in hepatocellular carcinoma. Cell death & disease 14 (12) (2023)
Chenyang Zheng, Bo Zhang, Yunyun Li, Kejia Liu, Wei Wei, Shuhang Liang, Hongrui Guo, Kun Ma, Yao Liu, Jia-Bei Wang, Lian-Xin Liu
Donafenib and GSK-J4 Synergistically Induce Ferroptosis in Liver Cancer by Upregulating HMOX1 Expression. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Heng Li, Yao Liu, Can Cheng, Yang Wu, Shu-Hang Liang, Liang Wu, Hong Wang, Cong-Yin Tu, Han-Hui Yao, Fan-Zheng Meng, Bo Zhang, Wei Wang, Jia-Bei Wang, Lian-Xin Liu
UBE2O reduces the effectiveness of interferon-α via degradation of IFIT3 in hepatocellular carcinoma. Cell death & disease 14 (12) (2023)
Heng Li, Yao Liu, Can Cheng, Yang Wu, Shu-Hang Liang, Liang Wu, Hong Wang, Cong-Yin Tu, Han-Hui Yao, Fan-Zheng Meng, Bo Zhang, Wei Wang, Jia-Bei Wang, Lian-Xin Liu
UBE2O reduces the effectiveness of interferon-α via degradation of IFIT3 in hepatocellular carcinoma. Cell death & disease 14 (12) (2023)
Heng Li, Yao Liu, Can Cheng, Yang Wu, Shu-Hang Liang, Liang Wu, Hong Wang, Cong-Yin Tu, Han-Hui Yao, Fan-Zheng Meng, Bo Zhang, Wei Wang, Jia-Bei Wang, Lian-Xin Liu
UBE2O reduces the effectiveness of interferon-α via degradation of IFIT3 in hepatocellular carcinoma. Cell death & disease 14 (12) (2023)
Heng Li, Yao Liu, Can Cheng, Yang Wu, Shu-Hang Liang, Liang Wu, Hong Wang, Cong-Yin Tu, Han-Hui Yao, Fan-Zheng Meng, Bo Zhang, Wei Wang, Jia-Bei Wang, Lian-Xin Liu
UBE2O reduces the effectiveness of interferon-α via degradation of IFIT3 in hepatocellular carcinoma. Cell death & disease 14 (12) (2023)
Yufeng Liu, Linmao Sun, Hongrui Guo, Shuo Zhou, Chunxu Wang, Changyong Ji, Fanzheng Meng, Shuhang Liang, Bo Zhang, Yubin Yuan, Kun Ma, Xianying Li, Xinyu Guo, Tianming Cui, Ning Zhang, Jia-Bei Wang, Yao Liu, Lian-Xin Liu
Targeting SLP2-mediated lipid metabolism reprograming restricts proliferation and metastasis of hepatocellular carcinoma and promotes sensitivity to Lenvatinib. Oncogene (2022)
Hongrui Guo, Shuhang Liang, Yan Wang, Shuo Zhou, Dalong Yin, Shugeng Zhang, Jizhou Wang, Dehai Wu, Kun Ma, Yufeng Liu, Linmao Sun, Changyong Ji, Xianying Li, Huanran Zhou, Guangchao Yang, Xinyu Guo, Tianming Cui, Zihao Li, Yao Liu, Jia-Bei Wang, Lian-Xin Liu
Cytochrome B5 type A alleviates HCC metastasis via regulating STOML2 related autophagy and promoting sensitivity to ruxolitinib. Cell death & disease 13 (7) (2022)
Hao Wang, Wei Wei, Zhong-Yuan Zhang, Yao Liu, Bin Shi, Wen Zhong, Hou-Shun Zhang, Xin Fang, Chun-Lei Sun, Jia-Bei Wang, Lian-Xin Liu
TCF4 and HuR mediated-METTL14 suppresses dissemination of colorectal cancer via N6-methyladenosine-dependent silencing of ARRDC4. Cell death & disease 13 (1) (2021)
Dehai Wu, Yan Wang, Guangchao Yang, Shugeng Zhang, Yao Liu, Shuo Zhou, Hongrui Guo, Shuhang Liang, Yifeng Cui, Bo Zhang, Kun Ma, Congyi Zhang, Yufeng Liu, Linmao Sun, Jia-Bei Wang, Lian-Xin Liu
A novel mitochondrial amidoxime reducing component 2 is a favorable indicator of cancer and suppresses the progression of hepatocellular carcinoma by regulating the expression of p27. Oncogene 39 (38) (2020)

Jia-Bei Wang.css-eqlu8i{font-size:small;padding-left:4px;} (Jiabei Wang)

Publication Activity (10 Years)

Top Topics

Top Venues

Jia-Bei Wang (Jiabei Wang)